Anti-activin A antibodies and uses thereof
The disclosure provides compositions and methods relating to or derived from anti-activin A binding proteins, including antibodies. In particular embodiments, the disclosure provides fully human, humanized, and chimeric anti-activin A antibodies that bind human activin A, activin A-binding fragments and derivatives of such antibodies, and activin A-binding polypeptides comprising such fragments. Other embodiments provide nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having activin A-related disorders or conditions including cachexia related to gonadal cancer, other cancers, rheumatoid arthritis, and other diseases.
Amgen Inc.
A A A A C C C A A C A C A A A C A A A C C
A61P A61P A61P A61P C07K C07K C07K A61P A61P C07K A61P C07K A61P A61P A61K C07K A61P A61P A61P C07K C07K
inventional inventional inventional inventional additional additional inventional inventional inventional additional inventional additional inventional inventional additional additional inventional inventional inventional additional additional
Qing Keith Soo-Nyung Xiaolan Huiquan
Chen Kwak Zhou Han